HomeHealthBD to Present at the Wells Fargo 2022 Healthcare Conference

BD to Present at the Wells Fargo 2022 Healthcare Conference

Published on

<br /> BD to Present at the Wells Fargo 2022 Healthcare Conference<br />

PR Newswire



FRANKLIN LAKES, N.J.


,


Aug. 24, 2022


/PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on

Wednesday, September 7, 2022

at

12:30pm Eastern Time

.

The live webcast of BD’s presentation can be accessed from the BD investor relations website,

investors.bd.com

. A replay of the event will be available on the same webpage following its conclusion.


About BD


BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit

bd.com

or connect with us on LinkedIn at

www.linkedin.com/company/bd1/

and Twitter

@BDandCo

.



Contacts:



Media

:



Investors

:


Troy Kirkpatrick


Francesca DeMartino


VP, Public Relations


SVP, Investor Relations


858.617.2361


201.847.5743



[email protected]



[email protected]

Cision
View original content to download multimedia:

https://www.prnewswire.com/news-releases/bd-to-present-at-the-wells-fargo-2022-healthcare-conference-301611858.html

SOURCE BD (Becton, Dickinson and Company)

rt BD to Present at the Wells Fargo 2022 Healthcare Conference

Featured image: © kritiya

Disclaimer

Latest News

Aetna 2023 Medicare plans put money back in members’ pockets

Aetna 2023 Medicare plans put money back in...

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Fezolinetant

European Medicines Agency Accepts Astellas' Marketing Authorization Application...

Biogen Announced EMA Filing Acceptance of BIIB800, A Biosimilar Candidate Referencing RoACTEMRA® (tocilizumab)

CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) -- ...

Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

Q&M Group awards 7 dentists with Performance Shares,12-year...

More like this

Numinus to Participate in the Cantor Neurology and Psychiatry Conference on October 6-7, 2022

VANCOUVER, BC, Sept. 29, 2022 - Numinus Wellness Inc. ("Numinus" or the "Company")(TSX:NUMI)(OTCQX:NUMIF), a mental...

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health

Illumina Unveils Revolutionary NovaSeq X Series to Rapidly...

AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn’s Disease and Ulcerative Colitis at the UEG Week 2022

AbbVie Highlights Robust Gastroenterology Portfolio with New Data...

Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.

CHICAGO, IL / ACCESSWIRE / September 28, 2022 / Cosmos Holdings d/b/a Cosmos Health,...

Moderna Creates New Executive Committee Role Ahead of New Product Launches

Juan Andres Appointed to President, Strategic Partnerships and Enterprise ExpansionJerh Collins Joins Moderna as...